Nektar Therapeutics
Closed
64.87 -0.12
Overview
Share price change
24h
Min
63.16
Max
65.3
Income | -8.8M -45M |
|---|---|
Sales | -11M 11M |
EPS | -1.82 |
Profit margin | -413.443 |
Employees | 63 |
EBITDA | -19M -38M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +137.39% upside |
Next Earnings | 6 Aug 2026 |
|---|
Market Cap | -681M 2.3B |
|---|---|
Previous open | 64.99 |
Previous close | 64.87 |
Nektar Therapeutics Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
137.39% upside
12 Months Forecast
Average 154.33 USD 137.39%
High 192 USD
Low 80 USD
Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$